The mission of EpiPredict is to train a multidisciplinary cohort of young researchers in a new approach to fully exploit the epigenetics of complex diseases. The 12 early-stage researchers (ESRs) will focus on a narrowly defined case, Tamoxifen-induced resistance in Estrogen Receptor positive (ER+) breast cancer, considering five interacting resistance pathways. Read more...
Please visit our news page for the latest announcements and press or our Facebook or Twitter pages!
2019-02-18
Anchal Nigam published a blog ‘Your Immune System: A friend or a foe?’ on the dual personality of immune cells and their contribution to resistance development for endocrine treatment as noted in ER+ breast cancer tumour cells.
2019-02-08
The first EpiPredict fellow, Rohit Bharat, received his PhD degree 8 February 2019 at the University of Milano-Bicocca, UNIMIB, Milan, Italy. Rohit worked on identifying metabolic rewiring of endocrine resistance pathways in ER+ breast cancer.
2018-09-03
View the updated #SysEpi2018 conference poster and flyer!
2018-07-23
The paper 'Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer' led by Luca Magnani is published online in Nature Medicine!
2018-07-12
View the updated #SysEpi2018 conference poster and flyer!
2018-06-06
View the updated #SysEpi2018 conference poster and flyer!
2018-06-01
EpiPredict researchers describe state-of-the-art methods to study epigenetic reprogramming of cell.
2018-05-29
Interview with Pernette Verschure in the UvA Science newsletter.
2018-05-03
During the Science Cafe meeting at Maggie's centre West London, EpiPredict PhD students presented their research to breast cancer (ex) patients and had engaging conversations about how patients and scientists could work together better.
2018-05-03
CRISPR CRISPR CRISPR! - Everybody talks about it, but what is it really?! In our new blog with EpiPredict fellow Emre Sofyali we answer exactly this question!
2018-04-03
View the #SysEpi2018 conference poster and flyer with all the relevant data, including the confirmed speakers!
2018-03-18
Dr Pernette Verschure gave a scientific lecture for children answering the question 'Why are we human all so different from each other?' in Nemo Science museum Amsterdam.
2018-02-13
Insides from Breast Cancer researcher Dr Luca Magnani from Imperial College London, UK. EpiPredict PhD fellow Simone Borgoni, from the German Cancer Research Centre, DKFZ, DE, interviewed Dr Magnani and wrote a blog for Medium.
2018-02-09
We are honored to announce the conference ‘Systems Epigenetics: Towards Precision Cancer Medicine’ that we organize in Amsterdam, the Netherlands on 27-30 November 2018.
2018-01-29
In this video Daniel Vilar Jorge explains why we study epigenetics in the resistance to endocrine therapy in breast cancer. It was first publicly presented during our first Science Café organized at DKFZ, Heidelberg, 2017.
2017-10-26
Désirée Goubert gave a TEDx talk in Groningen entitled ‘Epigenetics: the molecular traffic lights of our genetic railway’
We are honored to announce the conference ‘Systems Epigenetics: Towards Precision Cancer Medicine’ that we organize in Amsterdam, the Netherlands on 27-30 November 2018.
Second EpiPredict Science Café at Maggie's Centre, in front of Charing Cross Hospital
Imperial College London, UK, Thursday 14, December, 2017
At this Imperial Science Cafe (ex-) patients and their representatives were invited to talk about epigenetic influences on breast cancer therapy resistance.
To view the flyer, click here.
Epigenetics, everything you always wanted to know
DKFZ, Heidelberg, DE, Thursday 26 January, 2017, 13:30-17:00
Keynote speaker: Prof. Henk Stunnenberg, Radboud University Medical Centre, NL
Science café: Applying epigenetics in breast cancer treatment